Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Topotecan × 90 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 8 Ovarian Neoplasms 5 Neuroblastoma 5 Uterine Cervical Neoplasms 3 Neoplasms 3 Ganglioneuroblastoma 3 Sarcoma, Ewing 2 Fallopian Tube Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Thrombocythemia, Essential 1 Rhabdoid Tumor 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Medulloblastoma 1 Lymphoma, Follicular 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡